StockData
Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc. (HEPA) stock

HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)

Close on Oct 19, 2026Market cap $7.26MP/E –Yield –

Hepion Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Hepion Pharmaceuticals's total assets was $5.01M at Sep 30, 2026. For fiscal 2025 it was $3.07M, up 90.2% from the year before. Over ten years it grew 4.4% a year on average. The highest annual figure on record is $103.55M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.07M+90.2%
FY2024Dec 31, 2024$1.61M-91.1%
FY2023Dec 31, 2023$18.09M-70.0%
FY2022Dec 31, 2022$60.24M-41.8%
FY2021Dec 31, 2021$103.55M+112.9%
FY2020Dec 31, 2020$48.65M+136.0%
FY2019Dec 31, 2019$20.61M+12.1%
FY2017Jun 30, 2017$18.38M+40.3%
FY2016Jun 30, 2016$13.11M+143.7%
FY2015Jun 30, 2015$5.38M+168.7%
FY2014Jun 30, 2014$2.00M+2207.4%
FY2013Jun 30, 2013$86.72K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Sep 30, 2026$5.01M+33.8%
Q2 FY2026CQ2 2026Jun 30, 2026$1.93M-57.2%
Q1 FY2026CQ1 2026Mar 31, 2026$2.71M-57.2%
Q4 FY2025CQ4 2025Dec 31, 2025$3.07M+90.2%
Q3 FY2025CQ3 2025Sep 30, 2025$3.74M+0.7%
Q2 FY2025CQ2 2025Jun 30, 2025$4.51M-25.0%
Q1 FY2025CQ1 2025Mar 31, 2025$6.32M-60.5%
Q4 FY2024CQ4 2024Dec 31, 2024$1.61M-91.1%
Q3 FY2024CQ3 2024Sep 30, 2024$3.72M-85.1%
Q2 FY2024CQ2 2024Jun 30, 2024$6.01M-83.5%
Q1 FY2024CQ1 2024Mar 31, 2024$15.99M-67.7%
Q4 FY2023CQ4 2023Dec 31, 2023$18.09M-70.0%
Q3 FY2023CQ3 2023Sep 30, 2023$25.00M-64.1%
Q2 FY2023CQ2 2023Jun 30, 2023$36.50M-56.3%
Q1 FY2023CQ1 2023Mar 31, 2023$49.50M-48.4%
Q4 FY2022CQ4 2022Dec 31, 2022$60.24M-41.8%
Q3 FY2022CQ3 2022Sep 30, 2022$69.70M-37.5%
Q2 FY2022CQ2 2022Jun 30, 2022$83.57M-30.2%
Q1 FY2022CQ1 2022Mar 31, 2022$95.86M-22.5%
Q4 FY2021CQ4 2021Dec 31, 2021$103.55M+112.9%
Q3 FY2021CQ3 2021Sep 30, 2021$111.60M+448.0%
Q2 FY2021CQ2 2021Jun 30, 2021$119.75M+397.2%
Q1 FY2021CQ1 2021Mar 31, 2021$123.76M+431.8%
Q4 FY2020CQ4 2020Dec 31, 2020$48.65M+136.0%
Q3 FY2020CQ3 2020Sep 30, 2020$20.36M-3.4%
Q2 FY2020CQ2 2020Jun 30, 2020$24.08M+3.2%
Q1 FY2020CQ1 2020Mar 31, 2020$23.27M+194.4%
Q4 FY2019CQ4 2019Dec 31, 2019$20.61M+12.1%
Q3 FY2019CQ3 2019Sep 30, 2019$21.07M+79.2%
Q2 FY2019CQ2 2019Jun 30, 2019$23.34M+45.3%
Q1 FY2019CQ1 2019Mar 31, 2019$7.90M-10.3%
Q4 FY2017CQ2 2017Jun 30, 2017$18.38M+40.3%
Q3 FY2017CQ1 2017Mar 31, 2017$11.76M+74.2%
Q2 FY2017CQ4 2016Dec 31, 2016$16.07M+50.9%
Q1 FY2017CQ3 2016Sep 30, 2016$8.82M+208.9%
Q4 FY2016CQ2 2016Jun 30, 2016$13.11M+143.7%
Q3 FY2016CQ1 2016Mar 31, 2016$6.75M–
Q2 FY2016CQ4 2015Dec 31, 2015$10.65M–
Q1 FY2016CQ3 2015Sep 30, 2015$2.85M–
Q4 FY2015CQ2 2015Jun 30, 2015$5.38M–

More Hepion Pharmaceuticals figures

See a number that looks wrong?